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Abstract: Recent reports have highlighted the biological
activity associated with a subfamily of the tetramic acid class
of natural products. Despite the fact that members of this
subfamily act as protein–protein interaction inhibitors that are
of relevance to proteasome assembly, no synthetic work has
been reported. This may be due to the fact that this subfamily
contains an unnatural 4,4-disubstitued glutamic acid, the
synthesis of which provides a key challenge. A highly
stereoselective route to a masked form of this unnatural
amino acid now enabled the synthesis of two of the possible
diastereomers of JBIR-22 and allowed the assignment of its
relative and absolute stereochemistry.
Natural products that contain the tetramic acid motif have
been studied extensively, and their complexity and biological
profiles have led to several total syntheses.[1] For example,
equisetin, a close structural analogue of the compounds
studied here, has been prepared.[1a–c] However, the synthesis
of members of a subfamily that contain an unnatural 4,4-
disubstituted glutamic acid unit (1–4, Figure 1) is an unmet
challenge.[2] The biological activity displayed by members of
this subfamily justifies the development of a concise and
general approach for their synthesis.
Examples of the important activity shown by this sub-
family include the inhibition of the CCR5 receptor by
Sch210972 (1).[2a,b] A number of CCR5 receptor antagonists
are in clinical trials or in use as antiretroviral drugs.[3,4] In
addition, JBIR-22 (2) is the first example of a tetramic acid
that acts as a protein–protein interaction (PPI) inhibitor.[2c,d]
Compound 2 inhibits the homodimerization of the protea-
some assembly chaperone 3 (PAC3), an important protein
involved in the formation of the proteasomal machinery. The
clinical success of bortexomib,[5] a proteasome inhibitor,
supports the study of compounds that target the proteasome
or its formation. The fact that the stereochemical assignment
of 2[2c] was incomplete when our work began further high-
lights the need for synthetic studies on this subfamily of
tetramic acids.
Although chemical[6] and enzymatic[7] syntheses of 4-hy-
droxy-4-methylglutamic acid have been developed, a synthesis
of 4-hydroxy-4-iso-propylglutamic acid has not yet been
reported, which could be a factor in the lack of synthetic
work done on this subfamily. Here we report a short,
stereoselective synthesis of a 4,4-disubstituted glutamic acid
derivative and the application of this methodology to the first
total synthesis of 2. Our studies enabled the assignment of the
relative and absolute stereochemistry of 2.
Our initial synthetic plan was based on the synthesis of
1,3-amino alcohols (e.g. 5). This methodology involved the
diastereoselective addition of a metalloenamine 6 to an
aldehyde followed by diastereoselective imine reduction
(Scheme 1).[8] We proposed that the reaction of 7 with ethyl
dimethylpyruvate could establish the required stereogenic
center of the tertiary alcohol. Subsequent diastereoselective
reduction of the resulting b-hydroxy-N-sulfinyl ketimine 8
could give 9, a precursor of a protected form of the unnatural
amino acid 10 (Scheme 1). If accessible, 10 could potentially
be used in the synthesis of 2 in an analogous manner to that
previously demonstrated for other tetramic acids containing
Figure 1. A subfamily of tetramic acid natural products containing an
unnatural 4,4-disubstituted glutamic acid unit. Syntheses of 1–4 have
not been reported thus far. The shown relative and absolute stereo-
chemistry of 2 was assigned by our study.
[*] A. R. Healy, Prof. A. M. Z. Slawin, Prof. N. J. Westwood
School of Chemistry and Biomedical Sciences Research Complex
University of St Andrews and EaStCHEM
North Haugh, St Andrews, Fife (UK)
E-mail: njw3@st-andrews.ac.uk
Dr. M. Izumikawa
Japan Biological Informatics Consortium (JBIC) 2-4-7 Aomi
Koto-ku, Tokyo 135-0064 (Japan)
Dr. K. Shin-ya
National Institute of Advanced Industrial Science and
Technology (AIST)
2-4-7 Aomi, Koto-ku, Tokyo 135-0064 (Japan)
[**] We are grateful to Prof. Andrew Smith and Alyn Davies for
assistance performing chiral GC analyses, Carolyn Horsburgh,
Tomas Lebl, and the EPSRC National Mass Spectrometry Service
Centre, Swansea. Financial support was provided by Cancer
Research UK (CRUK Grant No. C21383/A6950).
Supporting information for this article is available on the WWW
under http://dx.doi.org/10.1002/anie.201411141.
 2015 The Authors. Published by Wiley-VCH Verlag GmbH & Co.
KGaA. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly
cited.
.Angewandte
Communications
4046  2015 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2015, 54, 4046 –4050
natural amino acids, such as equisetin.[1a–c,9] It also seemed
plausible that the tertiary alcohol in 8 or 9 may cyclize to
generate a lactone (e.g. 11 from 9). If this occurred, N-
methylation of 11 and removal of the N-sulfinyl group could
give the masked 4,4-disubstituted glutamic acid derivative 12.
Conversion of 12 to members of this subfamily was consid-
ered achievable.
The synthesis of 7 was achieved by condensation of (RS)-
tert-butanesulfinamide with ethyl pyruvate (8). Using the
reported conditions,[10] 7 was obtained in only 30% yield with
the major product being lactone 13 (13 :7= 5:3, Scheme 2).
The formation of 13 likely occurred in situ through an
Ti(OEt)4-catalyzed aldol reaction of 7 with ethyl pyruvate
(8) followed by lactonization (Scheme S1). Although 13 was
not required for the preparation of 2, it could be used in
a future synthesis of 1. Optimization of the synthesis of 7
resulted in its isolation in 60% yield (Table S1). Reaction of 7
with ethyl dimethylpyruvate gave the related lactone 14
(Scheme 2) with excellent diastereoselectivity and yield. As
expected, 14 was confirmed as the (Rs,2S) diastereomer by
X-ray analysis (Scheme 2).[8,11] N-methylation of 14 pro-
ceeded in high yield to provide 15. While an initial screening
of reducing agents gave only recovered lactone 15, the use of
NaBH3CN with HCl (4n in dioxane) resulted in the
diastereoselective (d.r.> 98%) reduction of 15 with cleavage
of the N-sulfinyl group to give 12 (Scheme 2). The stereo-
chemistry of 12 was assigned by NOE analysis (Scheme 2 and
Figure S1). Further analysis suggested that this reaction
proceeded by acid deprotection of the N-sulfinyl group
followed by the reduction with NaBH3CN (Scheme S2). The
observed diastereoselectivity was rationalized based on the
preferred approach of the reducing agent from the same side
as the ester. This efficient route provided the masked 4-
hydroxy-4-isopropyl glutamic acid 12 in just four steps from 8.
With 12 in hand, a synthesis of 2 was attempted because of
its unique activity as a PPI inhibitor and the uncertainty
associated with its stereochemical assignment. Izumikawa
et al. had shown that 2 could be assigned as one of the four
stereoisomers shown in Table 1 (diastereomers 2a and 2b and
their enantiomers 2c and 2d).[2c] Given the relatively large
distance between the decalin moiety and the unnatural amino
acid stereogenic center in 2, it is difficult to assign the relative
configuration of these two units. A convergent route to access
optically enriched samples of diastereomers 2a and 2b was
therefore investigated (Scheme 3).
The tetramic acid core in 2a would be formed at a late
stage, inspired by the conversion of 3-oxo-homoserine
Scheme 1. Ellman’s stereoselective synthesis of 1,3-amino alcohols.[8] A
possible synthesis of the required unnatural amino acid or a cyclized
version. Reagents and conditions: a) diastereoselective aldol reaction;
b) diastereoselective reduction; c) lactonization; d) N-methylation and
cleavage of the N-sulfinyl group; e) N-methylation and protecting
group manipulation.
Scheme 2. Condensation of 8 and (RS)-tert-butanesulfinamide gave
lactone 13 and 7 in a 5:3 ratio. Reagents and conditions: a) (RS)-tert-
butanesulfinamide, Ti(OEt)4, Table S1 for optimization; b) (i) LDA,
THF, 0 8C. (ii) Ethyl dimethylpyruvate, ZnBr2, 78 8C, 88%, d.r.>98%;
c) LiHMDS, iodomethane, DMF, 15 8C!RT, 95%; d) (i) HCl (4n in
dioxane), THF, 0 8C, 10 min. (ii) NaBH3CN, MeOH, 1.5 h, 0 8C, 85%,
d.r.>98%. X-ray analysis of 14 confirmed the expected (Rs,2S)
stereochemistry. The stereochemistry of 12 was determined using
NOE analysis (Figure S1). Scheme 3. Retrosynthetic analysis of JBIR-22 diastereomer 2a.
Table 1: Stereochemical assignment of four of the possible stereoiso-
mers of 2 (as reported in reference [2c]).[a] The absolute configuration of
stereoisomer 2a is depicted.
Compound
Glutamic acid
side chain
Decalin ring
2a 5’S,7’S 2S,3S,6R,11S
2b 5’S,7’S 2R,3R,6S,11R
2c 5’R,7’R 2R,3R,6S,11R
2d 5’R,7’R 2S,3S,6R,11S
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lactones to simple tetramic acids through a Claisen-like
intramolecular reaction (Scheme S3).[12] A Lacey–Dieckmann
condensation of fragment 16 would form the tetramic acid
core and provide the unnatural 4,4-disubstituted glutamic
acid side chain in one step. Fragment 16 could be accessible
through the coupling of 12 and the b-ketothioester 17a. A
late-stage convergent step such as this could ultimately
facilitate the coupling of alternate b-ketothioesters to
enable access to the other members of this subfamily
(Figure 1) or novel analogues. We envisaged that the decalin
b-ketothioester could be assembled through an asymmetric
Diels–Alder cycloaddition followed by manipulation to
introduce the thioester functionality (Schemes 4 and 5).
Assembly of 17a/b began with an Schreiber ozonolysis[13]
of cyclohexene to give acetal 18. Horner–Wadsworth–
Emmons (HWE) olefination of 18 using phosphonate 19
provided 20 (8:1 mixture of inseparable E,E :E,Z isomers,
Scheme 4). The acid-mediated deprotection of 20 gave dienal
21, which was reacted with Wittig reagent 22, followed by
acetal hydrolysis to give the trienal 23 (85% E,E,E geome-
try). Trienal 23 was then subjected to an organocatalytic
intramolecular Diels–Alder (IMDA) reaction using MacMil-
lans conditions (Scheme 5).[14] Both enantiomers of 24 were
accessed with good enantioselectivities (see Scheme 5 and the
Supporting Information for chiral GC analysis). The minor
E,Z,E isomer present in the sample of 23 was inert in this
IMDA reaction, thus enabling the purification to give either
24a or 24b, depending on which enantiomer of the organo-
catalyst was used (Scheme S4).[14] Elaboration of 24a and 24b
to give b-ketothioesters 17a and 17b, respectively, was
achieved through an aldol reaction using S-tert-butyl thioa-
cetate to give 25a or 25b, respectively, as an inconsequential
mixture of diastereomers, followed by oxidation with Dess–
Martin periodinane[15] (Scheme 5).
The final stages involved a silver trifluoroacetate medi-
ated coupling of 12 with either enantiomer of fragment 17 to
give 26a and 26b, following the protocol developed by the
Ley group for the synthesis of equisetin (Scheme 6).[1b,16]
Finally, cyclization onto the lactone in 26a and 26b and
microwave-assisted ester hydrolysis gave separate samples of
the optically enriched diastereomers 2a and 2b, which were
purified by reverse-phase chromatography. No evidence of
epimerization at the C5 position was observed.[17]
The assignment of the relative stereochemistry of 2 was
completed by comparison of the reported spectroscopic
data[2c] for 2 with those obtained for our synthetic samples
of 2a and 2b. This analysis revealed very similar 1H NMR
signals, but clear differences in the 13C NMR spectra, with the
signals reported for the isolated sample of 2 all being within
 0.1 ppm of those obtained for diastereomer 2a. In contrast,
there were significant differences when the data was com-
pared to that for diastereomer 2b (Figure 2 for selected
examples and Table S2). Further evidence for the identical
relative stereochemistry in 2 and diastereomer 2a came from
doping experiments using UPLC-TOFMS (Figure 2). These
studies showed that upon mixing of a sample of natural 2
(retention time= 3.3 min) with 2a, an increase in the size of
the peak at 3.3 min was observed, whereas doping of natural 2
Scheme 5. Synthesis of b-ketothioesters 17a (Scheme 3) and 17b.
Reagents and conditions: a) 20 mol% (S,S)-imidazolidinone TfOH,
MeCN (2% H2O), 5 8C, 48 h, 65%, 87% ee, d.r. 4:1. b) 20 mol%
(R,R)-imidazolidinone TfOH, MeCN (2% H2O), 5 8C, 48 h, 68%,
84% ee, d.r. 4:1. c) (i) LDA, S-tert-butyl-thioacetate, THF, 78 8C,
30 mins. (ii) 24a/24b, THF, 78 8C, 2 h, 25a (66%); 25b (69%).
d) Dess–Martin periodinane, DCM, RT, 2 h, 17a (79%); 17b (82%).
Scheme 6. Synthesis of JBIR-22 diastereomers 2a and 2b. Reagents
and conditions: a) 12, AgCF3CO2, Et3N, THF, 0 8C!RT, 2 h, 25a—
89%; 25b—84%. b) (i) tBuOK, THF, 0 8C!RT, 2 h. (ii) Aq. NaOH,
EtOH, 110 8C (MW), 20 mins, 2a—71%; 2b—74% over 2 steps.
Scheme 4. Synthesis of 23. Reagents and conditions: a) KHMDS,
diethyl 2-butenylphosphonate (19), DME, 78 8C!RT, 69%, E :Z=8:1;
b) Aq. HCl, THF, RT, 12 h, 94%; c) (i) (1,3-dioxolan-2-ylmethyl)triphe-
nylphosphonium bromide (22), tBuOK, THF, 0 8C, 3.5 h. (ii) 10% aq.
oxalic acid, RT, 1 h, 89%.
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with 2b led to the appearance of a different peak with
a retention time of 3.6 min. Comparison of the specific
rotation of 2a ( a½ 23D¼+ 75.08, c= 0.1, MeOH) with that
obtained for natural 2 ( a½ 23D¼+ 62.08, c= 0.1, MeOH)[18]
enabled the assignment of the absolute configuration of 2 as
(2S, 3S, 6R, 11S, 5’S, 7’S).
In summary, a highly stereoselective synthesis of the
masked 4,4-disubstituted glutamic acid 12 enabled the first
total synthesis of highly enantioenriched samples of two of the
possible diastereomers of JBIR-22 (2) by a concise, con-
vergent strategy. The diastereomers 2a and 2b were synthe-
sized in ten steps (longest linear route from cyclohexene) in
10.1% and 11.3% overall yield, respectively. The synthesis of
two of the possible stereoisomers facilitated the assignment of
both the relative and absolute configuration of the naturally
occurring protein–protein interaction inhibitor 2. The devel-
opment of a short, stereoselective synthesis of 12 coupled with
the convergent nature of this approach should facilitate the
future synthesis and biological assessment of all members of
this subfamily of natural products as well as novel analogues.
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